Helus Pharma, which serves as the commercial operating name for Cybin Inc. and operates as a clinical-stage pharmaceutical enterprise focused on developing novel mental health and psychiatric therapeutics, trades publicly on the NASDAQ stock exchange under the ticker symbol HELP. Investors looking to track its market performance, historical pricing charts, or corporate filings use this specific ticker symbol across major financial platforms. The company focuses heavily on advanced drug discovery pipelines targeting neurological conditions, and its shares fluctuate dynamically during market trading hours based on clinical trial updates, regulatory developments, and broader biotechnology sector trends.